EUVIMEDTutustu EUVIMEDiin
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?

Hiromichi Fujino iD

BioEssays · 2025-09 · 47 (9)

DOI: 10.1002/bies.70046 ↗

At a glance

Übersichtsarbeit in BioEssays, published online on 2025-07-23. Written by Hiromichi Fujino. Institution: Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima Universi…. Major MEDLINE topics: Receptors, Prostaglandin E, EP4 Subtype, Colorectal Neoplasms, Inflammatory Bowel Diseases, Interleukin-4. Cited 3 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Society for the Promotion of Science.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

In this article, onset mechanisms of colorectal cancer and intestinal bowel diseases (IBD) are postulated to involve the aberrant expression/hyper‐activation of E‐type prostanoid 4 (EP4) receptors. Although prostaglandin E 2 and EP4 receptors are important factors for maintaining colorectal homeostasis, their mediated signaling is also considered to be involved in the etiology of severe intestinal diseases. To prevent uncontrollable activations of EP4 receptors, two safety factors are proposed: butyrate as an external safety factor and interleukin (IL)‐4 as an internal safety factor. Thus, for maintaining vulnerable colorectal homeostasis, the levels of EP4 receptors, butyrate, and IL‐4 are proposed as an important triad for protecting against development/onset risks of, at least, EP4 receptor‐mediated cancer and IBD.

Subjects

MeSH terms (MEDLINE)

Receptors, Prostaglandin E, EP4 SubtypeColorectal NeoplasmsInflammatory Bowel DiseasesInterleukin-4ButyratesColonHumansHomeostasisAnimalsSignal Transduction

Author keywords

EP4 receptorsIBDbutyratecolorectal cancercolorectal homeostasisinterleukin‐4prostaglandin E2

Substances

Receptors, Prostaglandin E, EP4 SubtypeInterleukin-4Butyrates

Authors and institutions

  • Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.

ORCID profiles: Hiromichi Fujino

Funding

  • Japan Society for the Promotion of Science

Cite

APA

Fujino, H. (2025). Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?. BioEssays, 47(9). https://doi.org/10.1002/bies.70046

Vancouver

Fujino H. Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?. BioEssays. 2025;47(9). doi:10.1002/bies.70046

BibTeX
@article{Fujino2025,
  author = {Fujino, Hiromichi},
  title = {Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?},
  journal = {BioEssays},
  year = {2025},
  volume = {47},
  number = {9},
  doi = {10.1002/bies.70046}
}
Start for free →